AUS
NZ
UK
CA
USA
IND
Healthcare
Is Orthocell (ASX:OCC) Expanding Its Role in ASX All Ordinaries Biotech Sector?
April 17, 2026 11:39 AM AEST| By SamOrthocell completes a Remplir procedure in a US military hospital network, highlighting clinical deployment and biotechnology sector participation within ASX All Ordinaries.
ASX 200 Healthcare Sector Sees Rising Market Focus
April 17, 2026 11:27 AM AEST| By SamASX healthcare sector activity highlights market participation and corporate developments, reflecting integration of biotechnology and pharmaceutical companies across major indices.
ASX 300 Insight: Why Oneview Is Expanding CDIs?
April 17, 2026 10:47 AM AEST| By SamOneview Healthcare has expanded its CDI base through an ASX quotation, improving liquidity and accessibility while continuing to support its growth in digital healthcare solutions and patient engagement platforms.
ASX 300 Update: What’s Driving Firebrick Pharma’s Share Move?
April 17, 2026 10:39 AM AEST| By SamFirebrick Pharma has expanded its share base through an ASX quotation, enhancing liquidity and funding flexibility while shifting focus toward execution and development across its biotechnology pipeline.
Can BlinkLab’s Fresh Capital Drive Its Next Big Break?
April 16, 2026 05:06 PM AEST| By SamBlinkLab advances autism and ADHD diagnostics through funding, clinical trials, and real-world deployment, strengthening its digital healthcare platform and regulatory progress.
Is (ASX:BB1) Entering a New Phase in Digital Diagnostics?
April 16, 2026 03:33 PM AEST| By SamBlinkLab advances digital diagnostics with new funding, supporting clinical trials, regulatory expansion, and global deployment of its smartphone-based neurodevelopmental screening platforms.
ASX 100 Healthcare Giant: Why COH Shares Are Under Spotlight
April 16, 2026 10:04 AM AEST| By SamCochlear shares are under focus after a pullback, with healthcare resilience, global demand, and valuation dynamics shaping its outlook as a key ASX 100 medical technology company.
Is Lumos Diagnostics (ASX:LDX) Shaping ASX All Ordinaries Healthcare Landscape?
April 15, 2026 06:04 PM AEST| By SamLumos Diagnostics outlines reporting plans and investor engagement while advancing its share purchase plan, reflecting continued activity within the healthcare diagnostics sector.
All Ordinaries Spotlight: Orthocell Expands Remplir Access
April 15, 2026 01:06 PM AEST| By SamOrthocell expanded access to US military and veterans hospitals, advancing Remplir distribution and strengthening its presence in the global healthcare sector.
SHL Under Pressure: Hidden Opportunity in ASX 100 Healthcare?
April 15, 2026 10:41 AM AEST| By SamSonic Healthcare’s valuation and global presence highlight a defensive yet growth-oriented profile, with healthcare demand stability and international expansion shaping its outlook despite recent share price weakness.
Telix Bond Boost: Is ASX 100 Healthcare Story Resetting?
April 15, 2026 10:27 AM AEST| By SamTelix upsized its bond offering, strengthening financial flexibility and refining its capital structure, with future performance linked to clinical execution and global expansion in the healthcare sector.
Ryman Healthcare Sales Rise Despite Network Changes
April 15, 2026 10:13 AM AEST| By SamRyman Healthcare reported steady Q4 sales growth supported by strong occupancy and serviced apartment demand, maintaining resilience despite village closures and broader economic uncertainty affecting global markets.
Can PainChek’s US Deal Redefine Aged Care Tech?
April 14, 2026 06:33 PM AEST| By SamPainChek strengthens global presence through a US partnership, advancing AI-based pain assessment adoption across aged care facilities while scaling its reach in healthcare technology markets.
Is Entropy Neurodynamics Driving All Ords with Trial Gains?
April 14, 2026 05:07 PM AEST| By SamEntropy Neurodynamics advances clinical research with TRP program development, controlled infusion methods, and strengthened funding within the ASX healthcare sector.
Could This ASX Biotech Be Gearing Up for a Key Breakthrough?
April 14, 2026 04:53 PM AEST| By SamPercheron Therapeutics advances its oncology program with fresh funding, supporting clinical progress and upcoming research milestones in the evolving biotech landscape.
Can FebriDx Drive Lumos Diagnostics’ US Expansion?
April 14, 2026 04:46 PM AEST| By SamLumos Diagnostics accelerates FebriDx adoption across US urgent care centres, strengthening its commercial presence and supporting faster clinical decision-making in respiratory care.
Could Jupiter Unlock a New Rare Earths Breakthrough?
April 14, 2026 04:27 PM AEST| By SamCritica’s Jupiter project shows encouraging rare earth recovery progress, with advancing studies and optimisation efforts supporting future development in Western Australia’s resource sector.
Could Psychedelic Science Redefine Binge Eating Treatment?
April 14, 2026 04:23 PM AEST| By SamA clinical update highlights advancements in psychedelic therapy for binge eating disorder, showcasing controlled treatment methods, ongoing trials, and growing interest in innovative mental health solutions.
Aroa Biosurgery Gains as All Ordinaries Sees Healthcare Growth
April 14, 2026 04:00 PM AEST| By SamAroa Biosurgery operates within the healthcare sector using ECM technology, maintaining a debt-free structure while expanding commercial activity and reducing financial losses.
Can Percheron’s Fresh Funding Drive Its Cancer Therapy Forward?
April 14, 2026 02:39 PM AEST| By SamPercheron advances its cancer therapy with fresh funding, setting up the next clinical phase while drawing attention through upcoming research presentations and strategic progress.
Advertise your brand on Kalkine Media